All terms
Mergers and Acquisitions
Transactions in which one company acquires or combines with another — the dominant MedTech exit path, typically a strategic acquisition by an established player.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026
Definition
Mergers and Acquisitions (M&A) is the umbrella term for transactions where one company acquires or combines with another via stock purchase, asset purchase, merger, or tender offer. In MedTech, strategic acquisitions by established players (Medtronic, J&J MedTech, Boston Scientific, Stryker, Abbott, Edwards) account for the large majority of venture exits. Deal structures commonly include upfront cash, contingent value rights (CVRs) tied to FDA approval or revenue milestones, and earn-outs. What the regulation says
Antitrust review by FTC and DOJ under the Hart-Scott-Rodino Act (currently 2024 size-of-transaction threshold $119.5M, indexed annually). EU Merger Regulation review by the European Commission for qualifying transactions.
What this means in practice
MedTech M&A multiples vary widely by category: 4-8x revenue is typical for established players; 6-15x revenue or milestone-based earn-outs for high-growth platforms; pre-revenue deals are valued on probability-weighted future revenue. Common pitfalls
- •Accepting a high headline price weighted heavily toward earn-outs that buyers can disincentivize post-close.
- •Skipping pre-clearance HSR analysis on cross-border or category-leading deals.
Primary references
3 sourcesLink health: 1 verified 1 bot-blocked 1 needs review· last checked 2026-05-09
FTC·1eCFR·1PitchBook·1
- 1
FTC — Hart-Scott-Rodino FilingVerifiedFTCftc.gov
- 2
16 CFR 801 — Coverage Rules (HSR)Needs revieweCFRecfr.gov
- 3
PitchBook - MedTech CoverageBot-blockedPitchBookpitchbook.com
Inline markers like [1] jump to the matching reference above.